Effects of epoprostenol and sildenafil on right ventricular function in hypoxic volunteers: A tissue Doppler imaging study

European Journal of Applied Physiology

Volumn 112, Issue 4, 2012, Pages 1285-1294

  Pavelescu, Adriana ^a   Naeije, Robert ^a,b,c  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c Erasmus Campus ^*  (Belgium)

Author keywords

Echocardiography; Epoprostenol; Hypoxic pulmonary vasoconstriction; Pulmonary hypertension; Right ventricle; Sildenafil; Strain; Strain rate; TAPSE; Tissue Doppler imaging

Indexed keywords

ANTIHYPERTENSIVE AGENT; PIPERAZINE DERIVATIVE; PLACEBO; PROSTACYCLIN; PURINE DERIVATIVE; SILDENAFIL; SULFONE;

ADULT; ANALYSIS OF VARIANCE; ANOXIA; ARTICLE; BELGIUM; BLOOD PRESSURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPPLER ECHOCARDIOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ECHOGRAPHY; FEMALE; HEART OUTPUT; HEART RATE; HEART RIGHT VENTRICLE FUNCTION; HUMAN; MALE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PULMONARY ARTERY; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; STATISTICAL MODEL; TREATMENT OUTCOME; VASCULAR RESISTANCE;

ADULT; ANALYSIS OF VARIANCE; ANOXIA; ANTIHYPERTENSIVE AGENTS; BELGIUM; BLOOD PRESSURE; CARDIAC OUTPUT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, DOPPLER; EPOPROSTENOL; FEMALE; HEART RATE; HUMANS; HYPERTENSION, PULMONARY; LEAST-SQUARES ANALYSIS; LINEAR MODELS; MALE; PIPERAZINES; PLACEBOS; PREDICTIVE VALUE OF TESTS; PULMONARY ARTERY; PURINES; SULFONES; TREATMENT OUTCOME; VASCULAR RESISTANCE; VENTRICULAR FUNCTION, RIGHT; YOUNG ADULT;

EID: 84861349278     PISSN: 14396319     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00421-011-2085-y     Document Type: Article

References (42)

1. Borlaug BA, Melenovsky V, Marhin T, Fitzgerald P, Kass DA (2005) Sildenafil inhibits b-adrenergic-stimulated cardiac contractility in humans. Circulation 112:2642-2649
2. Champion HC, Michelakis ED, Hassoun P (2009) Comprehensive invasive and non invasive approach to the right ventricle pulmonary circulation unit: state of the art and clinical and research implications. Circulation 120:992-1007
3. Cremers B, Scheler M, Maack C, Wendler O, Schäfers HJ, Südkamp M, Böhm M (2003) Effects of sildenafil (Viagra) on human myocardial contractility, in vitro arrhythmias and tension of mammaria arteries and saphenous veins. J Cardiovasc Pharmacol 41:734-743
4. Dambrauskaite V, Herbots L, Claus P, Verleden G, Van Raemdonck D, Delcroix M, Sutherland GR (2003) Differential changes in regional right ventricular function before and after a bilateral lung transplantation: an ultrasonic strain and strain rate study. J Am Soc Echocardiol 16:432-436
5. Dambrauskaite V, Delcroix M, Claus P, Herbots L, D'hooge J, Bijnens B, Rademakers F, Sutherland GR (2007) Regional right ventricular dysfunction in chronic pulmonary hypertension. J Am Soc Echocardiol 20:1172-1180
6. Faoro V, Lamotte M, Deboeck G, Pavelescu A, Huez S, Guenard H, Martinot JB, Naeije R (2007) Effects of sildenafil on exercise capaciry in hypoxic normal subjects. High Alt Med Biol 8:155-163
7. Fassina G, Tessari F, Dorigo P (1983) Positive inotropic effect of a stable analog of PGI2 and of PGI2 on isolated guinea pig atria. Mechanism of action. Pharmacol Res Commun 15:735-749
8. Fesler P, Pagnamenta A, Rondelet B, Kerbaul F, Naeije R (2006) Effects of sildenafil on hypoxic pulmonary vascular function in dogs. J Appl Physiol 101:1085-1090
9. Galiè N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G (2005) Sildenafil use in pulmonary arterial hypertension (SUPER) study group. Sildenafil citrate therapy for pulmonary arteria hypertension. N Engl J Med 353:2148-2157
10. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G (2009) Task force for diagnosis and treatment of pulmonary hypertension of European Society of cardiology (ESC); European respiratory Society (ERS); International Society of heart and lung transplantation (ISHLT). Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34:1219-1263
11. Ghofrani HA, Wiedemann R, Rose F, Schermuly RT, Olschewski H, Weissmann N, Gunther A, Walmrath D, Seeger W, Grimminger F (2002) Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet 360:895-900
12. Ghofrani HA, Reichenberger F, Kohstall MG, Mrosek EH, Seeger T, Olschewski H, Seeger W, Grimminger F (2004) Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial. Ann Intern Med 141:169-177
13. Green M, Widdicombe JG (1966) The effects of ventilation of dogs with different gas mixtures on airway caliber and lung mechanics. J Physiol 186:363-381
14. Grunig E, Mereles D, Hildebrandt W, Swenson ER, Kübler W, Kuecherer H, Bärtsch P (2000) Stress Doppler echocardiography for identification of susceptibility to high altitude pulmonary edema. J Am Coll Cardiol 35:980-987
15. Guazzi M, Tumminelo G, Di Marco F, Guazzi MD (2004) Influences of sildenafil on lung function and hemodynamics in patients with chronic heart failure. Clin Pharmacol Ther 76:371-378
16. Hansen J, Sander M, Hald CF, Victor RG, Thomas GD (2000) Metabolic modulation of sympathetic vasoconstriction in human skeletal muscle: role of tissue hypoxia. J Physiol 527:387-396
17. Huez S, Retailleau K, Unger P, Pavelescu A, Vachiéry JL, Derumeaux G, Naeije R (2005) Right and left ventricular adaptation to hypoxia: a tissue Doppler imaging study. Am J Physiol 289:1391-1398
18. Huez S, Vachiéry JL, Unger P, Brimioulle S, Naeije R (2007) Tissue Doppler Imaging evaluation of cardiac adaptation to severe pulmonary hypertension. Am J Cardiol 100:1473-1478
19. Jamal F, Bergerot C, Argaud L, Loufouat J, Ovize M (2003) Longitudinal strain quantitates regional right ventricular contractile function. Am J Physiol 285:2842-2847
20. Karmazyn M (1986) Contribution of prostaglandins to reperfusioninduced ventricular failure in isolated rat hearts. Am J Physiol 251:131-140
21. Kaul S, Tei C, Hopkins JM, Shah PM (1984) Assessment of right ventricular function using two-dimensional echocardiography. Am Hear J 107:526-531
22. Kerbaul F, Brimioulle S, Rondelet B, Dewachter C, Hubloue I, Naeije R (2007) How prostacyclin improves cardiac output in right heart failure in conjunction with pulmonary hypertension. Am J Resp Crit Care Med 175:846-850
23. Kitabatake A, Inoue M, Asao M, Masuyama T, Tanouchi J, Morita T, Mishima M, Uematsu M, Shimazu T, Hori M, Abe H (1983) Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation 68:302-309
24. Kittipovanonth M, Bellavia D, Chandrasekaran K, Villaraga HR, Abraham TP, Pellikka PA (2008) Doppler myocardial imaging for early detection of right ventricular dusfunction in patients with pulmonary hypertension. J Am Soc Echocardiogr 21:1035-1041
25. Lewis GD, Lachmann J, Camuso J, Lepore JJ, Shin J, Martinovic ME, Systrom DM, Bloch KD, Semigran MJ (2007a) Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation 115:59-66
26. Lewis GD, Shah R, Shahzad K, Camuso JM, Pappagianopoulos PP, Hung J, Tawakol A, Gerszten RE, Systrom DM, Bloch KD, Semigran MJ (2007b) Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation 116:1555-1562
27. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J (2009) American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association. ACCF/AHA Expert Consensus Document on Pulmonary Hypertension: a Report of the American College of Cardiology Foundation Task Force on Expert Consensus documents and the American Heart Association. Circulation 119:2250-2294
28. Metsa-Ketela T (1981) Cyclic-AMP-dependent and independent effects of prostaglandins on the contraction-relaxation cycle of spontaneously beating isolated rat atria. Acta Physiol Scand 223:481-485
29. Missant C, Rex S, Claus P, Mertens L, Wouters PF (2008) Loadsensitivity of regional tissue deformation in the right ventricle: isovolumic versus ejection-phase indices of contractility. Heart 94:404-405
30. Nagendran J, Archer SL, Soliman D, Gurtu V, Moudgil R, Haromy A, St Aubin C, Webster L, Rebeyka IM, Ross DB, Light PE, Dyck JR, Michelakis ED (2007) Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility. Circulation 116:238-248
31. Phillips BG, Kato M, Pesek CA, Winnicki M, Narkiewicz K, Davison D, Somers VK (2000) Sympathetic activation by sildenafil. Circulation 102:3068-3073
32. Reffelmann T, Kloner RA (2003) Effects of sildenafil on myocardial infarct size, microvascular function and acute ischemic left ventricular dilatation. Cardiovasc Res 59:441-449
33. Rich S, McLaughlin VV (1999) The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension. J Am Coll Cardiol 34:1184-1187
34. Rondelet B, Kerbaul F, Van Benden R, Motte S, Fesler P, Hubloue I, Remmelink M, Brimioulle S, Salmon I, Ketelslegers JM, Naeije R (2004) Signaling molecules in overcirculation-induced pulmonary hypertension in piglets: effects of sildenafil therapy. Circulation 110:2220-2225
35. Stamler JS, Loh E, Roddy MA, Stamler JS, Creager MA (1994) Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 89:2035-2040
36. Takimoto E, Belardi D, Tocchetti CG, Vahebi S, Cormaci G, Ketner EA, Moens AL, Champion HC, Kass DA (2007) Compartimentalisation of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5. Circulation 115:2159-2167
37. Ueti OM, Camargo EE, Ueti Ade A, de Lima-Filho LC, Nogueira EA (2002) Assessment of right ventricular function with Doppler echocardiographic indices derived from tricuspid annular motion: comparison with radionuclide angiography. Heart 88:244-248
38. Vogel M, Schmidt MR, Kristianse SB, Cheung M, White PA, Sorensen K, Redington AN (2002) Validation of myocardial acceleration during isovolumic contraction as a novel noninvasive index of right ventricular contractility. Circulation 105:1693-1699
39. Wauthy P, Abdel Kafi S, Mooi WJ, Naeije R, Brimioulle S (2003) Inhaled nitric oxide versus prostacyclin in chronic shunt-induced pulmonary hypertension. J Thorac Cardiovasc Surg 126: 1434-1441
40. Winer BJ, Brow DR, Michels KM (1991) Statistical principles in experimental design, 3rd edn. McGrall-Hill, New York, pp 220-283
41. Yock PG, Popp RL (1984) Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 70:657-662
42. Zhao L, Mason NA, Morrell NW, Kojonazarov B, Sadykov A, Maripov A, Mirrakhimov MM, Aldashev A, Wilkins MR (2001) Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation 104:424-428